Beta Amyloid
Beta Amyloid inhibitors are compounds that target and prevent the formation or aggregation of beta-amyloid peptides, which are implicated in the pathogenesis of Alzheimer's disease. The accumulation of beta-amyloid plaques in the brain is a hallmark of the disease, leading to neuronal dysfunction and cognitive decline. Inhibitors of beta-amyloid aggregation are being explored as potential therapeutic agents to slow or prevent the progression of Alzheimer's disease. At CymitQuimica, we provide a range of beta-amyloid inhibitors to support your research in neurodegeneration, protein aggregation, and Alzheimer's therapy.
Found 266 products for "Beta Amyloid".
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Donanemab
CAS:Donanemab (LY3002813), a humanized IgG1 antibody, targets N-terminal Aβ for potential early Alzheimer's research.Purity:95%Color and Shape:Transparent LiquidMolecular weight:145.36 kDaEprodisate disodium
CAS:Eprodisate disodium (NC-503) is a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis.Formula:C3H6Na2O6S2Purity:99.88%Color and Shape:SolidMolecular weight:248.19Lecanemab
CAS:Lecanemab (BAN-2401) is an IgG1 monoclonal antibody targeting soluble aggregated beta amyloid (Abeta) for the study of cognitive disorders.Purity:95% - >95.0% (SDS-PAGE); 100% (SEC-HPLC)Color and Shape:Transparent LiquidMolecular weight:147.06 kDaLY 2389575 hydrochloride
CAS:LY2389575 hydrochloride is a selective mGlu3 NAM with 190 nM IC50, increases Mrc1, and aids Alzheimer's research.Formula:C15H16BrCl3N4Purity:99.9%Color and Shape:SolidMolecular weight:438.58Methoxy-X04
CAS:Methoxy-X04, a derivative of Congo red and Chrysamine-G, is a brain-permeable fluorescent probe for amyloid-β (Aβ).Formula:C23H20O3Purity:98.96%Color and Shape:SolidMolecular weight:344.4Ref: TM-T22972
1mg37.00€5mg79.00€1mL*10mM (DMSO)92.00€10mg123.00€25mg236.00€50mg416.00€100mg615.00€200mg874.00€ALZ-801
CAS:ALZ-801, an oral valine-prodrug of tramiprosate, enhances treatment of Alzheimer's by inhibiting β-amyloid aggregation with better PK and tolerance.Formula:C8H18N2O4SPurity:99.36%Color and Shape:SolidMolecular weight:238.3Glimepiride
CAS:Glimepiride (HOE-490) is a long-acting, third-generation sulfonylurea with hypoglycemic activity.Formula:C24H34N4O5SPurity:97.84% - 98.87%Color and Shape:White SolidMolecular weight:490.62Cromolyn sodium
CAS:Cromolyn sodium (FPL-670) is a chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells.Formula:C23H14Na2O11Purity:99.4% - 99.95%Color and Shape:White SolidMolecular weight:512.33Birtamimab
CAS:Birtamimab (NEOD001) is a monoclonal antibody selectively targeting and depleting amyloid protein, used in research on light chain amyloidosis.Purity:>95%Color and Shape:Transparent LiquidMolecular weight:146.44 kDaGantenerumab
CAS:Gantenerumab (R-1450) is a humanized antibody targeting amyloid-β (Aβ), used in studies of Alzheimer's disease.Purity:>95%Color and Shape:Transparent LiquidMolecular weight:146.28 kDaChlorzoxazone
CAS:Chlorzoxazone (Chlorzoxazon) is a Muscle Relaxant. The physiologic effect of chlorzoxazone is by means of Centrally-mediated Muscle Relaxation.Formula:C7H4ClNO2Purity:99.49% - 99.6%Color and Shape:White SolidMolecular weight:169.57p-HTAA
CAS:p-HTAA is a pentamer thiopheneacetic acid labeling Aβ deposits, used in amyloid research.Formula:C24H16O4S5Purity:98.68% - 99.09%Color and Shape:Yellow SolidMolecular weight:528.71APP669-711
APP669-711 is a peptide fragment comprising amino acids 669 to 711 of the amyloid precursor protein (APP). This peptide serves as a biomarker in Alzheimer's disease (AD) research and is useful for diagnosing amyloid deposition in the brain.Formula:C210H325N57O61S2Molecular weight:4685.35229QSH peptide
CAS:The QSH peptide is a polypeptide that specifically binds to Aβ1-42, and is employed in the synthesis of siRNA delivery complexes. It is applicable in research related to Alzheimer's disease (AD).Formula:C62H95N21O18Color and Shape:SolidMolecular weight:1422.55β-Amyloid (12-28) (TFA)
β-Amyloid (12-28) (TFA), a peptide fragment of the β-amyloid protein (β1-42)—a 42 amino acid protein primarily found in senile plaque cores—exhibits aggregationFormula:C91H136N25F3O27Color and Shape:SolidMolecular weight:2069.2Amilo-5MER sodium salt
Amilo-5MER sodium salt is an oral SAA inhibitor that reduces IL-6 and IL-1β release and is used in inflammation research.Formula:C23H39N6NaO9SPurity:99.28%Molecular weight:598.65β Amyloid(28-35) human
CAS:β-Amyloid(28-35) human is a neurotoxic β-amyloid peptide fragment that contributes to Alzheimer's disease pathogenesis by interacting with neuronal membranes,Formula:C36H67N9O9SColor and Shape:SolidMolecular weight:802.04Amyloid β-Protein (16-22)
CAS:Amyloid β-Protein (16-22) is a segment of the Aβ peptide.Formula:C43H64N8O10Molecular weight:853.02(Gly22)-amyloid β-protein(1-40)
CAS:Amyloid beta-protein(1-40) Arctic variant (Ab40ARC (E22G)), featuring a glycine at position 22 (Gly22), is a peptide utilized in Alzheimer's disease research [1Color and Shape:Solid(Pyr3)-Amyloid β-Protein (3-42)
CAS:(Pyr3)-Amyloid β-Protein (3-42) is the predominant amyloid β peptide structure found deposited in the brains of individuals with Alzheimer's disease and Down syndrome. It is thought that (Pyr3)-Amyloid β-Protein (3-42) accumulates in the brain, leading to the formation of insoluble amyloid β-peptide deposits.Formula:C196H299N53O55SColor and Shape:SolidMolecular weight:4307.19498
